According to a new report by Polaris Market Research, the global GLP-1 market was valued at USD 52.82 billion in 2025 and is projected to reach USD 133.92 billion by 2034, expanding at a CAGR of 10.9% over the forecast period. Growth is underpinned by rising type 2 diabetes prevalence, expanding demand for obesity treatment, and accelerating adoption of oral and long-acting drug formulations...